hCAII-IN-9 is a potentcarbonic anhydrase inhibitor withIC₅₀s of 1.18 μM (hCA II), 0.17 μM (hCA IX), and 2.99 μM (hCA XII), respectively. hCAII-IN-9 has no blood-brain barrier permeability^[1].

hCAII-IN-9 (compound 11) (100 μM; 24-48 h) inhibits BHK-21 and HEK-293 cells with cell viability rates of 48% and 72%^[1].

hCAII-IN-9 (compound 11) has no blood-brain barrier permeability^[1].

417.89

C₁₅H₁₆ClN₃O₅S₂

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.